PT  - JOURNAL ARTICLE
AU  - Brouwer, Andrew F.
AU  - Zahid, Mondal H.
AU  - Eisenberg, Marisa C.
AU  - Arnold, Benjamin F.
AU  - Ashraf, Sania
AU  - Benjamin-Chung, Jade
AU  - Colford, John M.
AU  - Ercumen, Ayse
AU  - Luby, Stephen P.
AU  - Pickering, Amy J.
AU  - Rahman, Mahbubur
AU  - Kraay, Alicia N.M.
AU  - Eisenberg, Joseph N.S.
AU  - Freeman, Matthew C.
TI  - Understanding the effectiveness of water, sanitation, and hygiene interventions: a counterfactual simulation approach to generalizing the outcomes of intervention trials
AID  - 10.1101/2022.11.15.22282349
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2022.11.15.22282349
4099  - http://medrxiv.org/content/early/2024/06/10/2022.11.15.22282349.short
4100  - http://medrxiv.org/content/early/2024/06/10/2022.11.15.22282349.full
AB  - Background While water, sanitation, and hygiene (WASH) interventions can reduce diarrheal disease, many large-scale trials have not found the expected health gains for young children in low-resource settings. Evidence-based guidance is needed to inform interventions and future studies.Objectives We aimed to estimate how sensitive the intervention effectiveness found in the WASH Benefits Bangladesh randomized controlled trial was to underlying WASH contextual and intervention factors (e.g.., baseline disease prevalence, compliance, community coverage, efficacy) and to generalize the results of the trial other contexts or scenarios.Methods We developed a disease transmission model to account for transmission across multiple environmental pathways, multiple interventions (water (W), sanitation (S), hygiene (H), nutrition (N)) applied individually and in combination, adherence to interventions, and the impact of individuals not enrolled in the study. Leveraging a set of mechanistic parameter combinations fit to the WASH Benefits Bangladesh trial (n=17,187) using a Bayesian sampling approach, we simulated trial outcomes under counterfactual scenarios to estimate how changes in intervention completeness, coverage, compliance, and efficacy, as well as preexisting WASH conditions and baseline disease burden, impacted intervention effectiveness.Results Increasing community coverage had the greatest impact on intervention effectiveness (e.g., median increases in effectiveness of 34.0 and 45.5% points in the WSH and WSHN intervention arms when increasing coverage to 20%). The effect of community coverage on effectiveness depended on how much transmission was along pathways not modified by the interventions. Intervention effectiveness was reduced by lower levels of preexisting WASH conditions or increased baseline disease burden. Individual interventions had complementary but not synergistic effects when combined.Discussion To realize the expected health gains, future WASH interventions must address community coverage and transmission along pathways not traditionally covered by WASH. The effectiveness of individual-level WASH improvements will be blunted the further the community is from the high community coverage needed to achieve herd protection.Competing Interest StatementANMK's contributions were directly funded by the Bill & Melinda Gates Foundation and not as part of the foundation grant to the authors. All other authors declare no conflicts of interest.Clinical Protocols https://www.medrxiv.org/content/10.1101/2022.04.28.22274441v1 Funding StatementThis work was funded by the Bill & Melinda Gates Foundation (grant INV-005081) and the National Science Foundation (grant DMS-1853032). The original WASH-B Bangladesh trial was also funded by the Bill & Melinda Gates Foundation (grant OPPGD759).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study only used openly available human data that were originally located at: https://osf.io/tprw2/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe WASH Benefits Bangladesh data is publicly available at https://osf.io/tprw2/. The data and code underlying the results of this paper are available at https://doi.org/10.5281/zenodo.10950560. https://github.com/afbrouwer/WASH_RCT_transmission_modeling https://doi.org/10.5281/zenodo.8057236